RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1154
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1243100; Gene model (P.falciparum): PF3D7_0528500; Gene product: F-actin-capping protein subunit alpha, putative (CPalpha, CPα)
Details mutation: P. berghei cpα replacement with the complete P. falciparum cpα gene
Phenotype Oocyst; Sporozoite;
Last modified: 17 January 2015, 13:59
  *RMgm-1154
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25565321
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherGanter M, Matuschewski K
Name Group/DepartmentParasitology Unit
Name InstituteF-actin-capping protein subunit alpha, putative
CityBerlin
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1154
Principal namecpα(-)::PfCPα II(1) and III(1)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystReduced numbers of oocysts. Oocysts produce midgut sporozoites.
SporozoiteReduced numbers of oocysts. Oocysts produce midgut sporozoites. No sporozoites inside salivary glands.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
In the mutant the P. berghei cpα is replaced with the complete P. falciparum cpα gene. The P. falciparum gene is under the control of the P. berghei cpα promoter region

Protein (function)
One of the few conserved actin-binding proteins of Plasmodium parasites is the F-actin capping protein (CP), which is found in all eukaryotic organisms and metazoan cell types

CP binds in a calcium-independent manner to the fast growing (barbed) ends of F-actin, thereby blocking subunit exchange. CP also belongs to the defined set of proteins that are needed to reconstitute actin-based motility in vitro.

Active CP is composed of two subunits, CPα and CPβ, and production of recombinant active CP in Escherichia coli (E. coli) is typically only achieved by co-expression of both subunits

Plasmodium CPβ is encoded by a single open reading frame, whereas CPα is composed of nine small exons. Overall, Plasmodium CPα-subunits share approximately 19% amino acid sequence identity with other eukaryotic CPα-subunits, and 50-90% identity across different Plasmodium species.

The residues that contribute to actin binding and heterodimer formation are conserved.

CPβ-subunit of rodent malaria parasite P. berghei (PbCPβ) as an essential regulator of sporozoite motility and malaria transmission. Deletion of PbCPβ did not influence asexual and sexual blood-stage development in the mammalian host. In the insect vector, Anopheles mosquitoes, mutant parasites displayed defective motility, which completely arrested life cycle progression at the sporozoite stage. It has been shown that recombinant P. berghei CPα/β heterodimers display capping activity on heterologous non-muscle actin. The stage-specific function of CPβ in sporozoites implies that CPα alone might be functional during blood infection of cpβ(-) parasites. Given that independent functions of CP subunits have not been described, this notion was unexpected and prompted to investigate the cellular role(s) of Plasmodium CPα for parasite life cycle progression.

In this study it is shown that the two CP subunits can be functionally separated. Unlike the beta subunit, the CPalpha subunit of the apicomplexan parasite Plasmodium is refractory to targeted gene deletion during blood infection in the mammalian host.

See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits

Phenotype
The phenotype analyses indicate that P. falciparum CPα can fully complement P. berghei CPα during blood stage development.
This result also suggests that the vital CPα function(s) during blood infection are apparently conserved between the  P. berghei and  P. falciparum. Together with  biochemical  characterization of PbCPα and the previously reported successful generation of a cpβ(-) mutant parasite (RMgm-328), these genetic findings indicate that the α-subunit can operate independently of the β-subunit.

However, the mutant shows strongly reduced numbers of oocysts in A. stephensi mosquitoes and absence of salivary gland sporozites, a phenotype which is comparable to mutants lacking expression of CPβ (RMgm-328).

A P. berghei mutant in which both the cpα and cpβ genes are replaced with the complete P. falciparum cpα and cpβ genes (RMgm-1157) shows a partial rescue of the phenotype with low numbers of sporozoites present in salivar glands.

Combined these observations indicate that a functional CP heterodimer is necessary for normal oocyst and sporozoite development

Additional information

Other mutants
See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1243100
Gene Model P. falciparum ortholog PF3D7_0528500
Gene productF-actin-capping protein subunit alpha, putative
Gene product: Alternative nameCPalpha, CPα
Details of the genetic modification
Short description of the mutationP. berghei cpα replacement with the complete P. falciparum cpα gene
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor targeted disruption of PbCPα, two fragments were amplified from P. berghei genomic DNA as template using primers PbCPα_forI and PbCPα_revII to amplify the 5’ flanking region, and PbCPα_forIII and PbCPα_revIV for amplification of the 3’ flanking region. Cloning into the P. berghei transfection plasmid b3D.DT^H.^D resulted in the plasmid pPbCPαrep.

In order to complement cpα(-) parasites, we amplified the orthologous P. falciparum CPα gene using the primers PfCPα_compforV and PfCPα_comprevVI and P. falciparum cDNA as template. Cloning into the plasmid pPbCPαrep resulted in the complementation plasmid pPfCPα.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6